OTCMKTS:OPSSF Opsens (OPSSF) Stock Price, News & Analysis → This could mean the end of the U.S dollar… (From Colonial Metals) (Ad) Free OPSSF Stock Alerts $2.14 +0.01 (+0.64%) (As of 12/13/2023) Add Compare Share Share Today's Range$2.12▼$2.1450-Day Range$2.14▼$2.1452-Week Range$0.97▼$2.14Volume36,000 shsAverage Volume44,497 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartShort InterestStock AnalysisAnalyst ForecastsChartShort Interest Get Opsens alerts: Email Address Ad True Market InsidersThe 1,000X Crypto PlaybookChris Rowe has created a “Crypto Playbook” that anyone can follow… potentially turning small investments into pers#1 Crypto for 2024, completely FREE. About Opsens Stock (OTCMKTS:OPSSF)Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for cardiovascular interventions. The company operates in two segments, Medical and Industrial. The company provides advanced optical-based pressure guidewire (OptoWire), a guidewire used in the transcatheter aortic valve replacement procedure; and a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated in other medical devices. It also develops, manufactures, and markets medical products; and offers OPP-GD fiber optic differential pressure sensors and the OEC fiber optic extensometer sensors. The company serves life sciences, energy, defense and aerospace, geotechnical, civil engineering, scientific laboratory, and various other markets. The company sells its products through a network of distributors and direct sales force in the United States, Japan, Canada, and internationally. Opsens Inc. was formerly known as Capital DCB inc. and changed its name to OpSens Inc. in October 2006. The company was founded in 2003 and is headquartered in Québec, Canada.Read More OPSSF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OPSSF Stock News HeadlinesMay 16, 2024 | americanbankingnews.comOpsens (OTCMKTS:OPSSF) Stock Price Passes Below 200-Day Moving Average of $2.13November 22, 2023 | marketwatch.comOpsens 4Q Loss Narrows, Revenue Tops ViewsNovember 2, 2023 | finance.yahoo.comOPSENS RECEIVES INTERIM ORDER AND FILES MANAGEMENT INFORMATION CIRCULAR IN CONNECTION WITH SPECIAL MEETING OF SHAREHOLDERSOctober 23, 2023 | finance.yahoo.comOPSENS ANNOUNCES THE POSITIVE CLINICAL RESULTS FROM THE SAFE-TAVI STUDY WITH SAVVYWIRE IN EUROPEOctober 17, 2023 | finance.yahoo.comOpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in San Francisco October 23 - 26, 2023October 5, 2023 | finance.yahoo.comOpsens' (TSE:OPS) investors will be pleased with their impressive 150% return over the last three yearsJune 20, 2023 | finance.yahoo.comOPS.TO - Opsens Inc.April 20, 2023 | finance.yahoo.comOpSens Announces Participation in the 2023 Bloom Burton & Co. Healthcare Investor ConferenceApril 6, 2023 | finance.yahoo.comOPSENS TO HOST SECOND QUARTER FISCAL YEAR 2023 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY APRIL 13, 2023February 28, 2023 | finance.yahoo.comOPSENS ANNOUNCES SAVVYWIRE™ USED DURING TWO LIVE CASES AT CRT CONFERENCEJanuary 12, 2023 | finance.yahoo.comOPSENS ANNOUNCES RECORD FIRST QUARTER FISCAL 2023 FINANCIAL RESULTSJanuary 11, 2023 | markets.businessinsider.comOpsens earnings: here's what Wall Street expectsJanuary 5, 2023 | finance.yahoo.comOPSENS TO HOST FIRST QUARTER FISCAL YEAR 2023 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY JANUARY 12, 2023December 22, 2022 | finance.yahoo.comOPSENS ANNOUNCES CLOSING OF $11.5 MILLION BOUGHT DEAL PUBLIC OFFERING INCLUDING $1.5 MILLION OVER-ALLOTMENT OPTION EXERCISED IN FULLNovember 29, 2022 | finance.yahoo.comOPSENS ANNOUNCES FIRST SAVVYWIRE™ PROCEDURE IN NEW ZEALANDSeptember 15, 2022 | finance.yahoo.comPromaxo Announces Research Collaboration with the University of Montreal Hospital Research Centre (CRCHUM) for Improved Prostate, Female GYN Cancer Management - Yahoo FinanceSeptember 15, 2022 | finance.yahoo.comInhibikase Therapeutics to Present Data from Phase 1/1b study of IkT-148009 at the Movement Disorders Society Congress - Yahoo FinanceSeptember 15, 2022 | finance.yahoo.comOPSENS ANNOUNCES FDA CLEARANCE FOR THE SAVVYWIRE™ FOR USE IN TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) PROCEDURESSeptember 14, 2022 | finance.yahoo.comOpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in Boston September 16-19, 2022 - Yahoo FinanceAugust 21, 2022 | finance.yahoo.comOpsens Inc. (OPSSF)July 15, 2022 | seekingalpha.comOpsens GAAP EPS of -$0.03, revenue of $10.1M beats by $3.01M (OTCMKTS:OPSSF) - Seeking AlphaJuly 14, 2022 | finance.yahoo.comOPSENS ANNOUNCES THIRD QUARTER FISCAL 2022 FINANCIAL RESULTS WITH RECORD QUARTERLY REVENUES - Yahoo FinanceJuly 11, 2022 | finance.yahoo.comOpSens Awarded Interventional Specialty Diagnostics Agreement with Premier for OptoWire IIIJuly 7, 2022 | finance.yahoo.comOPSENS TO HOST THIRD QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY, JULY 14May 20, 2022 | yahoo.com10 Summer Grocery Deals at TargetSee More Headlines Receive OPSSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Opsens and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings1/21/2014Today5/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:OPSSF CUSIPN/A CIKN/A Webopsens.com Phone(418) 781-0333FaxN/AEmployees293Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Alan W. Milinazzo (Age 63)Executive Chairman of the Board Comp: $73.47kMr. Louis Laflamme C.A.CPA, CPA, CEO, President & DirectorMr. Brad DavisChief Commercial OfficerMr. John HanniganChief Financial OfficerMr. Pierre PoulinCorporate ControllerKey CompetitorsAddLife AB (publ)OTCMKTS:ADDLFAnsellOTCMKTS:ANSLYAnsellOTCMKTS:ANSLFAsahi InteccOTC:AHICFBATM Advanced CommunicationsOTCMKTS:BTAVFView All Competitors OPSSF Stock Analysis - Frequently Asked Questions Should I buy or sell Opsens stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Opsens in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" OPSSF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OPSSF, but not buy additional shares or sell existing shares. View OPSSF analyst ratings or view top-rated stocks. How have OPSSF shares performed in 2024? Opsens' stock was trading at $2.1389 at the beginning of 2024. Since then, OPSSF stock has increased by 0.0% and is now trading at $2.1389. View the best growth stocks for 2024 here. How were Opsens' earnings last quarter? Opsens Inc. (OTCMKTS:OPSSF) posted its quarterly earnings results on Tuesday, January, 21st. The company reported ($0.01) EPS for the quarter. How do I buy shares of Opsens? Shares of OPSSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:OPSSF) was last updated on 5/23/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…StocksToTradeU.S. Drone Company Receives DoD CertificationThe Tomorrow InvestorTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaTruth about Trump you’ve never heardPorter & CompanyDividend-like income from non-dividend stocksUnstoppable ProsperityThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarAlex’s “Next Magnificent Seven” stocksThe Oxford ClubWhat is Nvidia’s New $1 Trillion Superproject?Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Opsens Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.